Compare WCCB & FTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WCCB | FTH |
|---|---|---|
| Founded | 2004 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 632.6M | 507.8M |
| IPO Year | 2026 | 2021 |
| Metric | WCCB | FTH |
|---|---|---|
| Price | $60.93 | $7.89 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 15 |
| Target Price | ★ $73.50 | $56.15 |
| AVG Volume (30 Days) | 85.7K | ★ 679.1K |
| Earning Date | 09-23-2026 | 11-03-2026 |
| Dividend Yield | ★ 1.90% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 4.17 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $7.07 | N/A |
| Revenue Next Year | $6.44 | N/A |
| P/E Ratio | $14.62 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $58.91 | $8.54 |
| 52 Week High | $64.32 | $42.14 |
| Indicator | WCCB | FTH |
|---|---|---|
| Relative Strength Index (RSI) | 37.72 | 23.28 |
| Support Level | $59.68 | N/A |
| Resistance Level | $61.95 | $21.97 |
| Average True Range (ATR) | 1.35 | 1.77 |
| MACD | -0.36 | -0.45 |
| Stochastic Oscillator | 15.56 | 0.40 |
West Coast Community Bancorp is a bank holding company. Through its banking subsidiary, it offers a full range of commercial and personal banking services to residents and businesses in Santa Cruz County and adjacent Monterey, San Luis Obispo, and Santa Clara counties. Its products and service offerings include mobile banking, credit and debit cards, treasury management, deposit products, such as checking, savings, and term certificate accounts, and lending products such as commercial, commercial real estate, construction, multifamily, municipal, asset-backed loans, etc. Its lending products also include various government guarantee programs such as Small Business Administration (SBA) and 504 programs, as well as U.S. Department of Agriculture (USDA) programs.
Faeth Therapeutics Inc is a clinical-stage biotechnology company focused on improving outcomes for cancer patients through multi-node inhibition of critical oncogenic pathways. The company's principal program is PIKTOR, an investigational all-oral combination of serabelisib and sapanisertib in development for endometrial and breast cancer.